Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Efficacy estimand: This analysis was not included in the statistical testing hierarchy, and as such, is hypothetical and was not controlled for multiplicity Study design OASIS 4 7,10 : A randomized, double-blind, placebo-controlled 64-week trial of 307 adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m-29.9 kg/m) and 1 weight-related comorbid condition, such as treated or untreated dyslipidemia or hypertension
Treatment usually continues until therapeutic goals are met or until the clinician determines that efficacy or tolerability is not acceptable
An individualised riskbenefit discussion with a specialist is appropriate for anyone in this group who may be considered for treatment in future
Are there any other medications or lifestyle choices I should make while tapering off semaglutide
Support levels vary
Underreporting medications : Some drugs interact with semaglutide and may cause nausea or hypoglycemia
US$ 28.98
US$ 22.51
US$ 24.45
US$ 29.73
